For all the lives lost and human suffering experienced as a result of this pandemic, the rapid biomedical response to this scourge has been a ray of light and hope. A number of open science approaches – including publishers making all of the relevant research open access – have led to accelerated genetic sequencing, vaccine development, three-phase clinical testing and approval and a global vaccination roll-out. The open science movement has also been spreading beyond the immediate questions of treating COVID-19.
It is influencing the opening of scholarly publishing, more generally, which is the area in which I work on . . . [more]